<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93142">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01892345</url>
  </required_header>
  <id_info>
    <org_study_id>ECU-NMO-301</org_study_id>
    <nct_id>NCT01892345</nct_id>
  </id_info>
  <brief_title>A Double Blind Trial To Evaluate The Safety And Efficacy Of Eculizumab In Relapsing NMO Patients (PREVENT Study)</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients With Relapsing Neuromyelitis Optica (NMO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexion Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexion Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to assess the efficacy and safety of eculizumab
      treatment as compared to placebo in relapsing NMO patients using a time to first relapse
      study design.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first relapse</measure>
    <time_frame>from baseline to end of study</time_frame>
    <description>On-trial NMO Relapse, as defined by the protocol.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall safety and tolerability of eculizumab</measure>
    <time_frame>from baseline to end of study</time_frame>
    <description>Adverse events, vital signs and laboratory assessments</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Neuromyelitis Optica</condition>
  <condition>Neuromyelitis Optica Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo contains the same buffer components without the active ingredient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eculizumab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction Phase: 900 mg IV weekly X 4
Maintenance Phase: 1200 mg IV every 2 weeks 6-104</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Eculizumab</intervention_name>
    <description>Induction Phase: 900 mg IV weekly X 4 Maintenance Phase: 1200 mg IV every two weeks 6-104
Drug: Placebo Other Names: Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Eculizumab</arm_group_label>
    <other_name>Soliris</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          1. Male or female patients ≥ 18 years old

          2. Diagnosis of NMO or NMO spectrum disorder

          3. All patients must be NMO-IgG seropositive

          4. Clinical evidence of at least 2 relapses in last 12 months or 3 relapses in the last
             24 months (with at least 1 relapse in the 12 months prior to the Screening)

          5. EDSS score ≤7

          6. Immunosuppressive therapy is allowed provided patients have been on a stable
             maintenance dose prior to the Screening and remain on a stable dose for the duration
             of the study

        Key Exclusion Criteria:

          1. Use of rituximab within 3 months prior to screening

          2. Use of mitoxantrone within 3 months prior to screening

          3. Use of IVIg within 3 weeks prior to screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alexion Pharmaceuticals (Sponsor)</last_name>
    <phone>1-855-687-1988</phone>
    <email>clinicaltrials@alxn.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alabama Neurology Associates</name>
      <address>
        <city>Homewood</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Barrow Neurological Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Research Center of Southern California</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>North Haven</city>
        <state>Connecticut</state>
        <zip>06473</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Christiana Care Neurology Spec,</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Miami McKnight Brain Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Neurological Services of Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allied Physicians Inc. of Fort Wayne</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Community Medical Associates, Inc.,</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Baptist Health Lexington</name>
      <address>
        <city>Nicholasville</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10466</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Multiple Sclerosis Comprehensive Care Center NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Health System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ohio Health Reserach Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania School of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Multiple Sclerosis Treatment Center of Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurology Center of San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Austral</name>
      <address>
        <city>Pilar</city>
        <state>Buenos Aires</state>
        <zip>B1629ODT</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Departamento de Investigaciones Clinicas Sanatorio Norte</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundacion Rosarina de Neuro Rehabilitacion</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000BZL</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General de Agudos Dr. J. M. Ramos Mejia</name>
      <address>
        <city>Ciudad Autonoma, Buenos Aires</city>
        <zip>C1221ADC</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General de Agudos Juan Antonio Fernandez</name>
      <address>
        <city>Ciudad Autonoma, Buenos Aires</city>
        <zip>C1425AGP</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ALPI-Inst. de Rehabilitacion Marcelo Fitte</name>
      <address>
        <city>Ciudad Autonoma, Buenos Aires</city>
        <zip>C1425BWO</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Brain and Mind Research Institute</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2232</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Griffith University</name>
      <address>
        <city>Gold Coast</city>
        <state>Queensland</state>
        <zip>4222</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Fitzroy</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LKH Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Klinik Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montreal Neurological Institute and Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 2B4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Fundacion Cardiovascular de Colombia</name>
      <address>
        <city>Floridablanca</city>
        <state>Santander</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Centre Zagreb</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VFN v Praze</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krajska zdravotni, a.s. - Nemocnice</name>
      <address>
        <city>Teplice</city>
        <zip>415 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Århus Universitetshospital</name>
      <address>
        <city>Århus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nimes</name>
      <address>
        <city>Nimes</city>
        <state>Gard</state>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Gui de Chauliac</name>
      <address>
        <city>Montpellier</city>
        <state>Languedoc-Roussillon</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Neurologique Pierre Wertheimer</name>
      <address>
        <city>Bron</city>
        <state>Rhone</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden Wuerttemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurologische Klinik und Poliklinik</name>
      <address>
        <city>Munich</city>
        <state>Bayern</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Regensburg</name>
      <address>
        <city>Regensburg</city>
        <state>Bayern</state>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Josef Hospital</name>
      <address>
        <city>Bochum</city>
        <state>Nordrhein Westfalen</state>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc.</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Heinrich Heine University</name>
      <address>
        <city>Dusseldorf</city>
        <state>Nordrhein Westfalen</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charite Universitaetsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Hong Kong - Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Shatin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione Istituto San Raffaele - G.Giglio di Cefalù</name>
      <address>
        <city>Palermo</city>
        <state>Sicilia</state>
        <zip>90015</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc.</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Binaghi, Università di Cagliari,ASL 8</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Policlinico di Catania</name>
      <address>
        <city>Catania</city>
        <zip>95123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione Instituto Neurologico Casimiro Mondino</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Camillo Forlanini</name>
      <address>
        <city>Rome</city>
        <zip>00152</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Sant'Andrea-Università di Roma La Sapienza</name>
      <address>
        <city>Rome</city>
        <zip>00178</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chiba University Hospital</name>
      <address>
        <city>Chiba-shi</city>
        <state>Chiba-Ken</state>
        <zip>260-8677</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hyogo College of Medicine Hospital</name>
      <address>
        <city>Nishinomiya-shi</city>
        <state>Hyogo-Ken</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kyoto Min-iren Chuo Hospital</name>
      <address>
        <city>Kyoto-shi</city>
        <state>Kyoto-Fu</state>
        <zip>604-8453</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tohoku University Hospital</name>
      <address>
        <city>Sendai-shi</city>
        <state>Miyagi-Ken</state>
        <zip>980-8574</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NHO Okinawa National Hospital</name>
      <address>
        <city>Ginowan-shi</city>
        <state>Okinawa-Ken</state>
        <zip>901-2214</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical and Dental University</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo-to</state>
        <zip>113-8519</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Musashino Red Cross Hospital</name>
      <address>
        <city>Musashino-shi</city>
        <state>Tokyo-To</state>
        <zip>180-8610</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Yamaguchi University Hospital</name>
      <address>
        <city>Ube-shi</city>
        <state>Yamaguchi-Ken</state>
        <zip>755-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kyushu University Hospital</name>
      <address>
        <city>Fukuoka</city>
        <zip>812-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NHO Nagasaki Kawatana Medical Center</name>
      <address>
        <city>Nagasaki</city>
        <zip>859-3615</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Niigata University Medical &amp; Dental Hospital</name>
      <address>
        <city>Niigata-shi</city>
        <zip>8520</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Center Hospital, NCNP</name>
      <address>
        <city>Tokio</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>410-769</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul University National Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>136-705</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University</name>
      <address>
        <city>Seoul</city>
        <zip>136-705</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>738-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Ewha Womans University Mokdong Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Kuala Lumpur</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Umum Sarawak</name>
      <address>
        <city>Kuching, Sarawak</city>
        <zip>93586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Republican Clinical Hospital for Rehabilitation of Healthcare Ministry of Republic of Tatarstan</name>
      <address>
        <city>Kazan</city>
        <zip>420021</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SBEI &quot;Krasnoyarsk SMU n.a. Prof. V.F. Voyno-Yasenetsky&quot;</name>
      <address>
        <city>Krasnoyarsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Healthcare Institution of city of Moscow &quot;City Clinical Hospital #11&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>127018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Federal State Budget Institution of Healthcare - Siberian District Medical Center of FMBA of Russia</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630068</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SEIHPE &quot;Rostov SMU of MoH of RF&quot;</name>
      <address>
        <city>Rostov-on Don</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Pavlov State Medical University of St.Petersburg</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint-Petersburg SHI &quot;City Clinical Hospital #31&quot;</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Neuroscience Institute</name>
      <address>
        <city>Tan Tock Seng</city>
        <zip>308433</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <state>Aragon</state>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Cruces</name>
      <address>
        <city>Barakaldo</city>
        <state>Bizkaia</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <zip>03010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia</name>
      <address>
        <city>Cordoba</city>
        <zip>14404</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de la Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>40447</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cheng Hsin General Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thammasat University Hospital</name>
      <address>
        <city>Pathum Thani</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hacettepe University Medical Faculty</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Trakya University Medical Faculty</name>
      <address>
        <city>Edirne</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmacueticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istanbul Bilim Universty Medical Fac.</name>
      <address>
        <city>Istanbul</city>
        <zip>34333</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istanbul University Cerrahpasa Medical Faculty</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istanbul University Istanbul Medical Faculty</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dokuz Eylul University Medicine Faculty</name>
      <address>
        <city>Izmir</city>
        <zip>35340</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kocaeli University Medical Faculty</name>
      <address>
        <city>Kocaeli</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ondokuz Mayis Univ. Med. Fac.</name>
      <address>
        <city>Samsun</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karadeniz Tecnical Uni. Med. Fac.</name>
      <address>
        <city>Trabzon</city>
        <zip>61100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Walton Centre</name>
      <address>
        <city>Liverpool</city>
        <zip>L97LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexion Pharmaceuticals, Inc</last_name>
      <email>clinicaltrials@alxn.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>Croatia</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>Spain</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.alexionclinicaltrials.com</url>
    <description>Alexion Clinical Trials Website</description>
  </link>
  <reference>
    <citation>Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013 Jun;12(6):554-62. doi: 10.1016/S1474-4422(13)70076-0. Epub 2013 Apr 26.</citation>
    <PMID>23623397</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 1, 2017</lastchanged_date>
  <firstreceived_date>June 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromyelitis Optica</keyword>
  <keyword>Neuromyelitis Optica Spectrum Disorder</keyword>
  <keyword>Devic's disease, Transverse Myelitis</keyword>
  <keyword>Optic Neuritis</keyword>
  <keyword>relapse</keyword>
  <keyword>eculizumab</keyword>
  <keyword>soliris</keyword>
  <keyword>NMO-IgG</keyword>
  <keyword>CNS Autoimmune Disorders</keyword>
  <keyword>Demyelinating Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neuromyelitis Optica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
